Krystexxa is a drug containing an enzyme pegloticase that can reduce uric acid levels by metabolizing uric acid in to harmless molecules which are readily excreted in the urine thus preventing the building up of uric acid concentration in our body. The drug is required to be administered to patients after every two weeks as an intravenous infusion.
Enzyme pegloticase is synthesized by using recombinant technology , where DNA of micro-organisms are genetically engineered so that they synthesize desired proteins , here it is pegloticase and human insulin too is synthesized by using this technology .
The enzyme pegloticase is further reacted with polyethylene glycol to form a covalent bonds between enzyme-Polyethylene glycol which is also known as peglytation so as to increase half-life of enzyme and make it available for longer duration for its desired action in body, this process can reduce the presentation of antigenic properties to body’s immune system , rendering the molecule lesser antigenic or reduce its immunogenicity. The process of formation of covalent bonding with PEG is known as PEGylation
Gout is a painful disease condition a where needle like crystals of uric acid get deposited in joints or in soft tissue , these crystals serve as a continuous painful sensation in joints or in soft tissue and at locations where ever they get deposited. These uric acid crystals cause intermittent swelling, redness, heat, pain and stiffness in the joints resulting in to a painful condition.
Uric acid crystals deposition (Gout ) occurs due to excess uric acid concentration in our body , which result from imbalanced metabolism of our body resulting in to high blood level of uric acid , which is normally associated with associated with obesity, high blood pressure, high cholesterol and diabetes, and occurs more often in men, in women after menopause, and in people with kidney disease.
The U.S. F DA has approved Krystexxa (pegloticase) to treat gout, a painful condition in adults who do not respond to or who are not able to tolerate other drug therapies.
Almost three percent of the three million adults suffering from gout do not get benefit from conventional therapy for gout, which is focused with administration of a drug that lower the amount of uric acid in the blood, like xanthine oxidase inhibitors Zyloprim (allopurinol) and Uloric (febuxostat).
It is observed in two six-month clinical trials where in 212 total patients on drug Krystexx were able to lower uric acid levels and reduced deposition of uric acid crystals in joints and soft tissue.
Almost one patient out of every four patients participated in Krystexx clinical trial experienced a severe allergic reaction while receiving an infusion of Krystexxa, hence it is advised that health care providers should dispense a corticosteroid and an antihistamine to their patients beforehand to minimize the risk of allergic reaction. Other reactions observed during the clinical trials are gout flare, nausea, injection site bruising, nasal passages irritation, constipation, chest pain and vomiting.
Physicians too are warned to be cautious while administering Krystexxa to patients with congestive heart failure as the drug was not studied in this group of patients.
US FDA has approved drug Krystexxa with a Risk Evaluation and Mitigation Strategy (REMS) that requires to includes a medication guide for patients and materials for healthcare providers to communicate the risk of severe allergic reactions during and after infusion of Krystexxa.
Krystexxa is contraindicated in patients with Glucose-6-phosphate dehydrogenase (G6PD) Deficiency:
Hence before Krystexxa treatment, patients should be screened for for G6PD deficiency (e.g., those of African and Mediterranean ancestry) as there is a risk of hemolysis and methemoglobinemia.
Krystexxa is manufactured by pharmaceutical company, Savient Pharmaceuticals Inc. of East Brunswick, N.J. USA
Do you know now this website has become a most popular and most referred website in pharmaceutical industry and pharmaceutical companies and pharmaceutical manufacturers from all over the world ,for almost all topics related to Pharmaceutical Manufacturing , Pharmaceutical Regulatory Affairs and Good Manufacturing Practice for Pharmaceutical Manufacturing (c GMP guidelines ) and latest news and new drugs developments.
You may also like following articles
Whar is Referance Listed Drug ? ( RLD )
What is Pharmaceutical Equivalents
What is Pharmaceutical Alternatives
What is Therapeutic Equivalents
Do Physical properties contribute to drug activity.
What is drug receptor , How a drug resistance occurs
Drug interaction, and its examples
What is first pass metabolism of a drug
What is What is 510(k) Clearances ?
Premarket Notification for medical devices – PMN or 510(k)
Antibiotic Definition and classification
Antibiotic resitance and Antibiotic resistance mechanism
Vitamin D Details on FDA cautions on accurate dosage of Vitamin D
What is an antibody? what is monoclonal and polyclonal antibodies?
Terminologies In vaccine Production
Multi stage testing of Virus vaccine production
Testing of vaccines at different stages of production
TESTING FOR ADVENTITIOUS AGENTS CELL PROPERTIES IN VIRAL VACCINE PRODUCTION
Enzyme linked immunosorbent assay ELISA
Pharmaceutical Aseptic Manufacturing Process Terms , Terminology and Definitions.
Here are some articles which will be useful for you in further understanding of aspects of sterile dosage form manufacturing and regulatory affairs and good manufacturing practice in
Types of validations in pharmaceutical manufacturing
Requirements of documents for validation of sterilisation process
How to investigate OOS out of specification results
Determination of Phenol coefficient of a disinfectant
Time limitations in sterile pharmaceuticals processing
Aspects of validation of manufacturing process in sterile pharmaceuticals
Controlling Pyrogens in injectable dosage forms
Media fill run process simulation aspects Validation of Aseptic Process and Sterilisation
New Drug Application (NDA) how to make a New Drug Application (NDA) to US FDA
Abbreviated New Drug Application (ANDA) What is ANDA , detaied information about ANDA preparation and submission to US FDA
How to make Investigational New Drug (IND) Application to US FDA
Drug applications submission to us fda Over the counter Drugs OTC drugs
BIOAVAILABILITY AND BIOEQUIVALENCE REQUIREMENTS
Electronic record in pharmaceutical manufacturing industry
Good manufacturing practice in pharmaceutical industry
Pharmaceutical industry pharmaceutical companies and FDA latest updates
Here is an interesting article on world wide pharmaceutical industry and making a carrier in one of pharmaceutical companies article on Pharmaceutical Industry pharmaceutical industry
Find a Job in Pharmaceutical Company
To Find Pharmaceutical jobs and make a Pharmaceutical careers see here pharmaceutical companies
Here are some interesting articles on Quality assurance systems for pharmaceutical company
1.Quality assurance in pharma industry
2.Quality by designe concept for pharmaceutical industry
3.Quality by designe concept in pharmaceutical industryan explanation